February 24, 2025 · Form 4 insider transaction
Maizel Ari bought 7,740 shares of Axsome Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock.; Each PSU will vest upon achievement of certain financial, regulatory and developmental performance milestones, subject to the reporting person's continued service as of each vesting date.